Medivir is a pharmaceutical company focusing on the development and commercialization of innovative treatments for cancer.
Medivir focuses on cancers of high unmet medical need to provide benefit to patients who so far have had few treatment options.Our projects >
Medivir leverages collaborations with academic and industrial partners in order to bring specialty knowledge, experience and other capabilities to our projects.Partnership >
Medivir receives the International Diamond Prize for Excellence in QualityRead more
MEDIVIR AB – INTERIM REPORT JANUARY – SEPTEMBER 2019Read more
Medivir reports last patient recruited to the phase Ia study of MIV-818 in liver cancer patients and initial dose determined for phase IbRead more
Partnering is an important element of our business strategy. Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale.